Hesperetin
CAS 520-33-2
Hesperetin (CAS 520-33-2) is a pharmaceutical compound with 8 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 13738.757246376812 nM | 69 | - |
| - | Potency | 17202.32619047619 nM | 34 | - |
| - | IC50 | 28541.731 nM | 19 | - |
| - | EC50 | 10000 nM | 7 | - |
| - | Ki | 4111.9 nM | 5 | - |
| - | MIC | 81 ug.mL-1 | 4 | - |
| - | GI50 | 36100 nM | 1 | - |
| - | Kd | 24500 nM | 1 | - |
| Carbonic anhydrase 4 Enzyme |
Ki | 6.99 | - | Homo sapiens |
| Carbonic anhydrase 12 Enzyme |
Ki | 6.34 | - | Homo sapiens |
| Carbonic anhydrase 7 Enzyme |
Ki | 8.48 | - | Homo sapiens |
| Dipeptidyl peptidase 4 Enzyme |
IC50 | 6.55 | - | Homo sapiens |
| Glycogen synthase kinase-3 beta Kinase |
IC50 | 4.57 | - | Homo sapiens |
| Cytochrome P450 1B1 Enzyme |
IC50 | 6.29 | - | Homo sapiens |
| Replicase polyprotein 1ab Enzyme |
IC50 | 5.08 | - | Human SARS coronavirus |
| Lysine-specific histone demethylase 1A Enzyme |
IC50 | 4.1 | - | Homo sapiens |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| HESPERETIN | 1314255 | SU | MTHSPL |
| hesperetin | 1314255 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Hesperetin used for in pharmaceutical contexts?
Hesperetin (CAS 520-33-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Hesperetin?
No adverse-event association or SIDER side-effect rows are rendered for Hesperetin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Hesperetin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Hesperetin with EU status "permitted".
What clinical phase is Hesperetin in?
No phase 1-4 clinical development badge is rendered for Hesperetin because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Hesperetin?
Hesperetin has 16 bioactivity rows in this page query. Rendered target entries include Carbonic anhydrase 4, Carbonic anhydrase 12, Carbonic anhydrase 7, Dipeptidyl peptidase 4, Glycogen synthase kinase-3 beta.